Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Phase I Open-Label, Dose-Escalation Study of NUC-3373, a Targeted Thymidylate Synthase Inhibitor, in Patients with Advanced Cancer (Nutide:301)

Pavlina Spiliopoulou,Farasat Kazmi,Francesca Aroldi, Thomas Holmes,David Thompson,Lucinda Griffiths,Cathy Qi,Matthew Parkes,Simon Lord,Gareth J. Veal,David J. Harrison,Vicky M. Coyle,Jill Graham,Thomas R. Jeffry Evans,Sarah P. Blagden

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH（2024）

Cited 0|Views27
Key words
NUC-3373,5-FU,5-fluorouracil,Fluoropyrimidines,Thymidylate synthase,Resistant cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined